Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 4

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 4
---
ATION                                                                     |     |  152 |
| DIRECTOR                                                                         
 COMPENSATION                                                                     |     |  159 |
| PRINCIPAL                                                                        
 STOCKHOLDERS                                                                     |     |  160 |
| CERTAIN                                                                          
 RELATIONSHIPS AND RELATED PARTY TRANSACTIONS                                     |     |  163 |
| DESCRIPTION                                                                      
 OF SECURITIES                                                                    |     |  165 |
| DESCRIPTION                                                                      
 OF SECURITIES WE ARE OFFERING                                                    |     |  179 |
| SECURITIES                                                                       
 ACT RESTRICTIONS ON RESALE OF OUR SECURITIES                                     |     |  183 |
| PLAN                                                                             
 OF DISTRIBUTION                                                                  |     |  184 |
| LEGAL                                                                            
 MATTERS                                                                          |     |  187 |
| EXPERTS                                                                          |     |  187 |
| WHERE                                                                            
 YOU CAN FIND MORE INFORMATION                                                    |     |  187 |
| INDEX                                                                            
 TO FINANCIAL STATEMENTS                                                          |     |  F-1 |

<div align='center'>i

ABOUT THIS PROSPECTUS</div>

You should rely only on
the information contained in this prospectus, any amendment or supplement to this prospectus, and any related free writing prospectus
prepared by or on behalf of us or to which we have referred you. Neither we nor the placement agent have authorized anyone to provide
you with information that is different from, or in addition to, that contained in this prospectus, any amendment or supplement to this
prospectus and any related free writing prospectus prepared by or on behalf of us or to which we have referred you.

Neither we nor the placement
agent take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you.
Neither we nor the placement agent will make an offer to sell these securities in any jurisdiction where such offer or sale is not permitted.
No dealer, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus,
any applicable prospectus supplement or any related free writing prospectus. You should assume that the information appearing in this
prospectus or any prospectus supplement is accurate as of the date on the front of those documents only, regardless of the time of delivery
of this prospectus or any applicable prospectus supplement, or any sale of a security. Our business, financial condition, results of
operations and prospects may have changed since those dates.

Neither we nor the placement
agent have